SynCore Biotechnology Co.,Ltd
4192.TWO
Price:
$25.75
Market Cap:
$905.50M
SynCore Biotechnology Co.,Ltd, engages in development and sale of food advisory, medicine inspection, and biotechnology service in Taiwan. The company is involved in the development of SB01, an injectable anti-cancer new ingredient (NCE) that is in Phase II clinical trials for the treatment of head and neck cancer; and SB02, an anti-cancer NCE, which is in preclinical research for use in the treatment of stomach cancer. It also offers SB03-Veregen, an ointment for the treatment of patients with external genital and perianal warts; and SB04,an conventional drug for the treatment of age-related macular degeneration that is in Phase II clinical trials. In addition, the company provides SB05-End...[Read more]
Industry
Biotechnology
IPO Date
2013-08-29
Stock Exchange
TWO
Ticker
4192.TWO
PE Ratio
[-19.51]
ROE
[-18.31%]
Current Ratio
[11.18]
Dividend Yield
[0%]
Enterprise Value
[730.95M]
Dividend History
The ROE as of December 2025 (TTM) for SynCore Biotechnology Co.,Ltd (4192.TWO) is -18.31%
According to SynCore Biotechnology Co.,Ltd’s latest financial reports and current stock price. The company's current ROE is -18.31%. This represents a change of 300.10% compared to the average of -4.58% of the last 4 quarters.
SynCore Biotechnology Co.,Ltd (4192.TWO) Historical ROE (quarterly & annually)
How has 4192.TWO ROE performed in the past?
The mean historical ROE of SynCore Biotechnology Co.,Ltd over the last ten years is -57.72%. The current -18.31% ROE has changed -68.28% with respect to the historical average. Over the past ten years (40 quarters), 4192.TWO's ROE was at its highest in in the December 2023 quarter at 11.65%. The ROE was at its lowest in in the December 2022 quarter at -32.82%.
Average
-57.72%
Median
-68.96%
Minimum
-103.54%
Maximum
-10.69%
SynCore Biotechnology Co.,Ltd (4192.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of SynCore Biotechnology Co.,Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 72.34%
Maximum Annual ROE = -10.69%
Minimum Annual Increase = -85.89%
Minimum Annual ROE = -103.54%
| Year | ROE | Change |
|---|---|---|
| 2024 | -18.42% | 72.34% |
| 2023 | -10.69% | -85.89% |
| 2022 | -75.77% | -26.82% |
| 2021 | -103.54% | 45.50% |
| 2020 | -71.16% | 6.58% |
SynCore Biotechnology Co.,Ltd (4192.TWO) Average ROE
How has 4192.TWO ROE performed in the past?
The current ROE of SynCore Biotechnology Co.,Ltd (4192.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-34.96%
5-year avg
-55.92%
10-year avg
-57.72%
SynCore Biotechnology Co.,Ltd (4192.TWO) ROE vs. Peers
How is 4192.TWO’s ROE compared to its peers?
SynCore Biotechnology Co.,Ltd’s ROE is greater than Andros Pharmaceuticals Co.,Ltd (-18.09%), greater than Eusol Biotech Co.,Ltd. (-10.52%), greater than NatureWise Biotech & Medicals Corporation (-5.58%), greater than LAUNXP Biomedical Co., Ltd (-56.54%), less than TCI GENE Inc. (3.64%), greater than PlexBio Co., Ltd. (-18.38%), greater than Lukas Biomedical Inc. (-31.59%), greater than Bio Preventive Medicine Corp. (-24.73%), greater than AmCad BioMed Corporation (-10.14%), less than Level Biotechnology Inc. (12.44%),
| Company | ROE | Market cap |
|---|---|---|
| -18.09% | $1.22B | |
| -10.52% | $835.70M | |
| -5.58% | $1.04B | |
| -56.54% | $1.10B | |
| 3.64% | $984.26M | |
| -18.38% | $894.49M | |
| -31.59% | $1.32B | |
| -24.73% | $1.14B | |
| -10.14% | $968.99M | |
| 12.44% | $1.08B |
Build a custom stock screener for SynCore Biotechnology Co.,Ltd (4192.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SynCore Biotechnology Co.,Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
SynCore Biotechnology Co.,Ltd (4192.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like SynCore Biotechnology Co.,Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is SynCore Biotechnology Co.,Ltd's ROE?
How is the ROE calculated for SynCore Biotechnology Co.,Ltd (4192.TWO)?
What is the highest ROE for SynCore Biotechnology Co.,Ltd (4192.TWO)?
What is the 3-year average ROE for SynCore Biotechnology Co.,Ltd (4192.TWO)?
What is the 5-year average ROE for SynCore Biotechnology Co.,Ltd (4192.TWO)?
How does the current ROE for SynCore Biotechnology Co.,Ltd (4192.TWO) compare to its historical average?